Retatrutide vs Semaglutide

Retatrutide wins for raw potency (up to −24% body weight loss in trials), targeting visceral and liver fat, increased energy expenditure via glucagon receptor activation, and breaking plateaus for users adapted to GLP-1/GIP agonists. It shows more depot fat and liver-fat loss, and delivers ongoing weight reduction at higher doses.

Semaglutide wins for proven safety, established sourcing and generic availability, side-effect predictability, flexible microdosing, and broader user experience. Its appetite suppression is clean, makes deep deficits sustainable, and protocols are well-dialed in the physique community. Minimal learning curve and lower risk of overdoing it.

Pick Retatrutide if:

• You want maximum fat loss (−20%+ body weight) as fast as possible.
• You've already adapted to semaglutide or tirzepatide and need an escalated effect.
• Visceral fat or liver fat (post-orals, health remodeling) is your main target.
• You want to combine appetite suppression with increased calorie burn (energy expenditure boost).
• You're willing to handle less-predictable sides and rapidly titrate.

Pick Semaglutide if:

• You want proven, steady appetite suppression for cut or recomp.
• You're looking for the safest, most studied peptide in this class.
• Microdosing (0.1–0.5 mg/week) is enough for your needs.
• You want easily sourced product with predictable GI sides and minimal surprises.
• You prefer lowest risk profile for long-term or indefinite use, or you're female (more trial data, established dosing).